Nuvectis Pharma, Inc.NVCTNASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+12.8%
5Y CAGR+387.6%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+12.8%/yr
Annual compound
5Y CAGR
+387.6%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
2757.4x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $27.57M | +38.9% |
| 2024 | $19.85M | -13.3% |
| 2023 | $22.90M | +19.0% |
| 2022 | $19.23M | +49.2% |
| 2021 | $12.89M | +128840.0% |
| 2020 | $10000.00 | - |